Zdravka Medarova
Founder chez TRANSCODE THERAPEUTICS, INC.
Fortune : 6 482 $ au 31/03/2024
Profil
Zdravka Medarova is the founder of TransCode Therapeutics, Inc., a company founded in 2016.
She holds the title of Chief Scientific Officer at TransCode Therapeutics, Inc. Currently, Dr. Medarova is also working as an Associate Professor at Harvard Medical School since 2016.
Dr. Medarova obtained her doctorate degree from the University of New Hampshire in 2002 and her undergraduate degree from the University of Southern Maine in 1998.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CLS HOLDINGS USA INC
0,09% | 31/12/2023 | 96 639 ( 0,09% ) | 4 832 $ | 31/03/2024 |
| 13/12/2023 | 2 416 ( 0,04% ) | 1 650 $ | 31/03/2024 |
Postes actifs de Zdravka Medarova
| Sociétés | Poste | Début |
|---|---|---|
| TRANSCODE THERAPEUTICS, INC. | Founder | 01/01/2016 |
| Harvard Medical School | Corporate Officer/Principal | 01/04/2016 |
Formation de Zdravka Medarova
| University of New Hampshire | Doctorate Degree |
| University of Southern Maine | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRANSCODE THERAPEUTICS, INC. | Health Technology |
